|
|
|
|
| LEADER |
01546nam a2200277 u 4500 |
| 001 |
EB002219844 |
| 003 |
EBX01000000000000001356805 |
| 005 |
00000000000000.0 |
| 007 |
tu||||||||||||||||||||| |
| 008 |
240703 r ||| eng |
| 100 |
1 |
|
|a Khangura, Sara
|
| 245 |
0 |
0 |
|a Suicide-specific psychotherapy for the treatment of suicidal crisis
|h Elektronische Ressource
|b a review of clinical effectiveness
|c Sara D. Khangura, Ismat Kanga, Kelsey Seal, Carolyn Sprys
|
| 250 |
|
|
|a Version 1.0
|
| 260 |
|
|
|a Ottawa (ON)
|b Canadian Agency for Drugs and Technologies in Health
|c 2018, May 2018
|
| 300 |
|
|
|a 1 PDF file (38 pages)
|
| 505 |
0 |
|
|a Includes bibliographical references
|
| 700 |
1 |
|
|a Kanga, Ismat
|e [author]
|
| 700 |
1 |
|
|a Seal, Kelsey
|e [author]
|
| 700 |
1 |
|
|a Spry, Carolyn
|e [author]
|
| 710 |
2 |
|
|a Canadian Agency for Drugs and Technologies in Health
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
| 490 |
0 |
|
|a CADTH rapid response report: summary with critical appraisal
|
| 856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK532315
|3 Volltext
|
| 082 |
0 |
|
|a 610
|
| 520 |
|
|
|a Suicide-specific psychotherapies have, nonetheless, been identified as potentially beneficial interventions for those at a high risk of suicide, or experiencing a suicidal crisis. Thus, this report aims to synthesize available evidence on the clinical effectiveness of suicide-specific psychotherapies, and comparative clinical effectiveness of suicide-specific psychotherapies in those experiencing a suicidal crisis
|